Skip to content
Screener

Verrica Pharmaceuticals Inc. VRCA Q2 2026 earnings

Reported August 6, 2026 · After market close

Revenue$5.9MBeat by $128.7K
EPS-$0.62Miss by $0.23
Revenue estimate$5.7M
EPS estimate-$0.39

Next report

Nov 13, 2026 (in 2 months)
Revenue estimate$6.4M
EPS estimate-$0.58

FAQ

When did Verrica Pharmaceuticals Inc. report Q2 2026 earnings?
Verrica Pharmaceuticals Inc. (VRCA) reported Q2 2026 earnings on August 6, 2026 after market close.
What were Verrica Pharmaceuticals Inc.'s Q2 2026 revenue and EPS?
Verrica Pharmaceuticals Inc. reported revenue of $5.9M and eps of $-0.62 for Q2 2026.
Did Verrica Pharmaceuticals Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $5.7M by $128.7K. EPS missed the consensus estimate of $-0.39 by $0.23.
How did Verrica Pharmaceuticals Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 53.8% from $12.7M a year earlier.
Where can I find Verrica Pharmaceuticals Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-338273) and the 10-Q periodic report (0001660334-26-000025) directly on SEC EDGAR. The filing index links above go to sec.gov.